News
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 BASIS study (NCT03938792) evaluating HYMPAVZI™ (marstacimab) for adults and ...
So-called ‘skinny jabs’ are being prescribed to people who don’t need them, with terrifying side effects. How did our ...
Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...
Cimzia (certolizumab pegol) is a prescription injection that treats Crohn’s disease, arthritis, and other conditions. Learn about side effects, dosage, and more.
27d
Health and Me on MSNMounjaro For Weight Loss: How It Works, Duration, Side Effects, Cost And MoreFor a lot of people, weight loss has nothing to do with willpower; it's got everything to do with biology. You might have heard the buzz around Mounjaro, perhaps your friend has been talking about it, ...
Spike in weight loss drug users overdosing One in five need hospital treatmentREAD MORE: Terrifying side effects of Ozempic emerge Aussies have been issued a warning about Ozempic as the number of ...
Avery Dennison has introduced a portfolio of RFID-enabled In-Mold Labels (IML) designed to be embedded into plastic items ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
German factory in Kierspe expands injection-moulding facilities to include monomaterial lip gloss bottles in PET and PCR ...
Wegovy is a prescription injection used for weight loss and reduction of cardiovascular risks. Learn about its dose escalation, form, strengths, and more.
AstraZeneca announced that the EC green-lighted the new formulation of the once-weekly type-2 diabetes injection, which will be marketed as Bydureon BCise (exenatide 2mg prolonged-release suspension).
Avonex (interferon beta-1a) is a prescription injection that treats relapsing forms of multiple sclerosis (MS) in adults. Learn about its dosage, side effects, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results